Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
41.11
+0.90 (2.25%)
At close: Jun 6, 2025, 4:00 PM
41.09
-0.01 (-0.04%)
After-hours: Jun 6, 2025, 5:59 PM EDT

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
7,6548,0834,7202,1151,8552,628
Upgrade
Market Cap Growth
23.85%71.26%123.15%14.03%-29.43%-
Upgrade
Enterprise Value
5,6856,6203,9691,5251,2782,195
Upgrade
Last Close Price
41.0943.7428.6823.8225.1739.59
Upgrade
PS Ratio
--407.5859.7863.1161.14
Upgrade
PB Ratio
3.683.572.583.093.085.54
Upgrade
P/TBV Ratio
3.813.682.693.463.516.58
Upgrade
EV/Sales Ratio
--342.7843.1143.4851.07
Upgrade
Debt / Equity Ratio
0.070.060.050.090.110.07
Upgrade
Asset Turnover
--0.010.050.050.11
Upgrade
Quick Ratio
13.2613.9712.8910.489.669.48
Upgrade
Current Ratio
13.4614.2013.0610.659.779.63
Upgrade
Return on Equity (ROE)
-36.68%-29.33%-34.75%-38.63%-34.73%-34.49%
Upgrade
Return on Assets (ROA)
-23.09%-18.66%-20.08%-20.83%-18.00%-17.56%
Upgrade
Return on Capital (ROIC)
-24.51%-19.97%-21.67%-22.76%-19.98%-20.96%
Upgrade
Earnings Yield
-9.11%-7.42%-9.25%-11.76%-10.09%-4.12%
Upgrade
FCF Yield
-7.86%-7.02%-7.59%-11.12%-8.29%-3.92%
Upgrade
Buyback Yield / Dilution
-32.89%-48.24%-40.34%-10.74%-32.68%-1879.16%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q